Status:
UNKNOWN
Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions:
Immune Thrombocytopenia
ITP
Eligibility:
All Genders
18+ years
Brief Summary
Multicenter retrospective and prospective observational study based on the collection of sequential anonymized data from principal Italian ITP centers, to describe the clinical course of ITP patients ...
Detailed Description
Multicenter retrospective and prospective observational study based on the collection - through pre-piloted electronic CRFs - of sequential anonymized data from principal Italian ITP centers represent...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Confirmed diagnosed of ITP (ITP could be past, ongoing, persistent \>3 months, chronic \>12 months) in patients that are in regular follow-up (at least once a year) and who have been diagnosed with COVID-19
- All patients who develop de novo ITP from 1st January 2020 to the end of study after a diagnosis of COVID-19 or during the first 6 months after COVID-19 recovery
- Signed informed consent
Exclusion
- • All subjects not fitting inclusion criteria
Key Trial Info
Start Date :
August 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04735588
Start Date
August 22 2022
End Date
March 1 2024
Last Update
August 26 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
ASST Degli Spedali Civili Di Brescia - UO Ematologia
Brescia, Italy
2
Unità di Onco-Ematologia - Azienda Ospedaliera Garibaldi
Catania, Italy
3
A.O.U. Careggi - Ematologia
Florence, Italy
4
AOU San Luigi Gonzaga - SCDU Ematologia Generale E Oncoematologia
Orbassano, Italy